Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Binodenoson

🥰Excellent
Catalog No. T9516Cas No. 144348-08-3
Alias WRC 0470, MRE-0470, 2-(cyclohexylmethylidenehydrazino)adenos

Binodenoson (WRC 0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].

Binodenoson

Binodenoson

🥰Excellent
Purity: 99.84%
Catalog No. T9516Alias WRC 0470, MRE-0470, 2-(cyclohexylmethylidenehydrazino)adenosCas No. 144348-08-3
Binodenoson (WRC 0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
Pack SizePriceAvailabilityQuantity
1 mg132 €In Stock
5 mg282 €In Stock
10 mg424 €In Stock
25 mg702 €In Stock
50 mg937 €In Stock
100 mg1.320 €In Stock
1 mL x 10 mM (in DMSO)310 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Binodenoson"

Select Batch
Purity:99.84%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Binodenoson (WRC 0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging[1].
Targets&IC50
A2A:270 nM(kd)
In vitro
2-(cyclohexylmethylidenehydrazino)adenos (30-300 nM) decreases oxidative activity of tumor necrosis factor-α–primed FMLP-stimulated polymorphonuclear leukocytes in human whole blood and acts synergistically with Rolipram[1].
In vivo
Binodenoson (infused 0-0.9 μg/kg/h; adult Wistar rat; rat bacterial meningitis model), with or without rolipram (0-0.01 μg/kg/h), inhibits pleocytosis and reduces the lipopolysaccharide-induced increase in blood-brain barrier permeability (BBBP), indicative of decreased neutrophil-induced damage[1].
AliasWRC 0470, MRE-0470, 2-(cyclohexylmethylidenehydrazino)adenos
Chemical Properties
Molecular Weight391.42
FormulaC17H25N7O4
Cas No.144348-08-3
SmilesNc1nc(N\N=C\C2CCCCC2)nc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Relative Density.1.76 g/cm3
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 11 mg/mL (28.1 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5548 mL12.7740 mL25.5480 mL127.7400 mL
5 mM0.5110 mL2.5548 mL5.1096 mL25.5480 mL
10 mM0.2555 mL1.2774 mL2.5548 mL12.7740 mL
20 mM0.1277 mL0.6387 mL1.2774 mL6.3870 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Binodenoson | purchase Binodenoson | Binodenoson cost | order Binodenoson | Binodenoson chemical structure | Binodenoson in vivo | Binodenoson in vitro | Binodenoson formula | Binodenoson molecular weight